StocktoriaNextCure, Inc. NXTC
Nasdaq · XNAS · stock · Pharmaceutical Preparations
Chart by TradingView
1/9
Piotroski F — financial health
-29.29
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$57.6M | -$59.7M | -$67.6M | -$75.9M | -$70.8M |
| Net income | -$55.8M | -$55.7M | -$62.7M | -$74.7M | -$69.4M |
| Operating cash flow | -$49.6M | -$40.8M | -$53.0M | -$53.9M | -$57.3M |
| Free cash flow | — | -$41.3M | -$53.8M | -$56.0M | -$59.6M |
| Total assets | $50.2M | $80.9M | $128.0M | $184.2M | $242.4M |
| Total liabilities | $15.2M | $15.4M | $13.6M | $16.6M | $9.0M |
| Shareholders' equity | $34.9M | $65.5M | $114.4M | $167.5M | $233.4M |
| Ratios | |||||
| Return on assets | -111.3% | -68.8% | -49.0% | -40.6% | -28.6% |
| Return on equity | -159.8% | -85.0% | -54.8% | -44.6% | -29.7% |
| Debt / equity | — | — | — | 0.00× | 0.00× |
| Current ratio | 4.14 | 7.50 | 16.38 | 17.97 | 34.48 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 60,534 | $646,503 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -29.29 (distress)
- Working capital / assets 0.661
- Retained earnings / assets -8.688
- EBIT / assets -1.148
- Equity / liabilities 2.293
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001661059 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.